about
Bipolar disorder and mechanisms of action of mood stabilizersFrontotemporal and dopaminergic control of idea generation and creative driveCorticosteroids in acute respiratory failureThe noradrenergic action in antidepressant treatments: pharmacological and clinical aspectsAnimal models of bipolar mania: The past, present and future.Predictive animal models of mania: hits, misses and future directions.The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitementBehavioral effects of levodopa.The diagnostic dilemma of pathological appearance and performance enhancing drug useEndophenotypes in bipolar disorder.Cognitive judgment bias in the psychostimulant-induced model of mania in rats.The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms.Anabolic-androgenic steroid use and psychopathology in athletes. A systematic reviewA neuroplastic deafferentation hypothesis for bipolar disorder.Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase AChronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case reportChronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.Recognition of bipolar disorder type I before the first manic episode: challenges and developments.Tamoxifen use for the management of mania: a review of current preclinical evidence.Is Mania the Hypertension of the Mood? Discussion of A Hypothesis.Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium.A case of chloroquine-induced recurrent mania.Animal models for bipolar disorder: from bedside to the cage.Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid.Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid.The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine.Prasterone (DHEA) and mania.Mood As Cumulative Expectation Mismatch: A Test of Theory Based on Data from Non-verbal Cognitive Bias Tests.
P2860
Q22252332-66C10509-32CF-4E7F-BB69-D1F924B6386DQ24649518-DAF75380-A9EF-4F47-B072-4F8439C4A7BEQ28145486-AC9A8A68-7CCD-40B9-9FC1-B539EF9BB540Q28300843-FB204675-CACA-4BDF-B2B4-09DA0F967DA5Q30357298-96D5F049-436F-4BE8-989D-2A1F3D400639Q30462823-2752FA26-3475-4FF6-BD44-B809FABAFFB0Q30484058-93F61754-5365-4A61-871E-0476693CEA83Q34452922-7450B035-9360-422E-82AF-7D021EA30951Q34574338-F38DF285-927A-47EB-8961-C33F1255BDD5Q34626051-F95EB7C1-6D63-4511-BA2A-520B69C6EAFCQ34996750-D0BA6E3B-A5FE-4C4B-AF9D-1C2722970248Q35054681-3C41A4BC-8BFE-4BDD-8D32-3E2D323A0C7AQ35308508-9EB8D04A-8E43-4756-98C8-938136FF9888Q35551673-BB4482F4-ED8F-4935-936C-92813C5D6F18Q35710533-1834995F-4BEF-4193-B991-1335477CBB82Q36306948-ADBC061F-A4B5-4C05-A0EF-A9A8AE0B618FQ36836802-F76E00AA-C2F3-4FB6-B11A-E4537D48DC41Q36930683-4F7A8171-5FAB-435C-9F4E-43A9FE512362Q37248070-4F5A4EFD-7D0C-4B74-80E6-416C3EBFF0E1Q37590122-FEBA85BB-A146-4EF5-85A7-44260845D380Q38125216-D94B75BC-6544-447D-AD20-3FCFE06711B8Q38179926-A78E6119-625A-40D3-A9C0-423CF7798FBEQ39305705-D099172D-AEC4-4A9B-9397-D44421C32054Q40262756-12A26CF5-895B-4F0C-85D4-0E9119F3113AQ41927993-5492A168-F683-40EC-86DF-50ECDB02C7A2Q42702891-121CC16B-3B4C-4EC6-9EF8-D12EEF2CE422Q45161646-ABB56665-0478-4613-ADC3-C510C4A8E639Q45894972-840AD208-9EC8-42B9-BA08-285673421ED2Q46423984-0B55B174-D074-4763-8BC9-395211ADCB7FQ47975522-B20BE487-2A78-4140-AFEC-DD272C838206Q51071364-40856A31-AA47-44D1-AAAF-535E0811AA7EQ55002928-4FCC5B87-6597-4FF5-B771-F8C97ACEFDA8
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Drug-induced mania.
@ast
Drug-induced mania.
@en
Drug-induced mania.
@nl
type
label
Drug-induced mania.
@ast
Drug-induced mania.
@en
Drug-induced mania.
@nl
prefLabel
Drug-induced mania.
@ast
Drug-induced mania.
@en
Drug-induced mania.
@nl
P1433
P1476
Drug-induced mania.
@en
P304
P356
10.2165/00002018-199512020-00007
P577
1995-02-01T00:00:00Z
P6179
1041276483